This tool predicts the probability of disease-free survival from attributes of a HSCT donor-recipient pair based on the research findings of HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide (Fuchs E, McCurdy S, et al., 2021). This retrospective study of 1434 patients use s a Cox proportional hazards model to better understand the effects of HLA locus-specific risks following haploidentical transplantation using PTC y.
This version of the tool is as published in the above reference. Disease-free Survival Predictor Tool v1.0.